Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

New targets for overactive bladder-ICI-RS 2109.

Fry CH, Chakrabarty B, Hashitani H, Andersson KE, McCloskey K, Jabr RI, Drake MJ.

Neurourol Urodyn. 2019 Nov 18. doi: 10.1002/nau.24228. [Epub ahead of print] Review.

PMID:
31737931
2.

TReatIng Urinary symptoms in Men in Primary Healthcare using non-pharmacological and non-surgical interventions (TRIUMPH) compared with usual care: study protocol for a cluster randomised controlled trial.

Frost J, Lane JA, Cotterill N, Fader M, Hackshaw-McGeagh L, Hashim H, Macaulay M, MacNeill SJ, Noble S, Rees J, Ridd MJ, Robles L, Taylor G, Taylor J, Drake MJ, Worthington J.

Trials. 2019 Sep 2;20(1):546. doi: 10.1186/s13063-019-3648-1.

3.

Tissue response to applied loading using different designs of penile compression clamps.

Lemmens JM, Broadbridge J, Macaulay M, Rees RW, Archer M, Drake MJ, Moore KN, Bader DL, Fader M.

Med Devices (Auckl). 2019 Jun 27;12:235-243. doi: 10.2147/MDER.S188888. eCollection 2019.

4.

Clinical and Patient-reported Outcome Measures in Men Referred for Consideration of Surgery to Treat Lower Urinary Tract Symptoms: Baseline Results and Diagnostic Findings of the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM).

Lewis AL, Young GJ, Abrams P, Blair PS, Chapple C, Glazener CMA, Horwood J, McGrath JS, Noble S, Taylor GT, Ito H, Belal M, Davies MC, Dickinson AJ, Foley CL, Foley S, Fulford S, Gammal MM, Garthwaite M, Harris MRE, Ilie PC, Jones R, Sabbagh S, Mason RG, McLarty E, Mishra V, Mom J, Morley R, Natale S, Nitkunan T, Page T, Payne D, Rashid TG, Saeb-Parsy K, Sandhu SS, Simoes A, Singh G, Sullivan M, Tempest HV, Viswanath S, Walker RMH, Lane JA, Drake MJ.

Eur Urol Focus. 2019 May;5(3):340-350. doi: 10.1016/j.euf.2019.04.006. Epub 2019 Apr 30.

PMID:
31047905
5.

Influence of sildenafil on the purinergic components of nerve-mediated and urothelial ATP release from the bladder of normal and spinal cord injured mice.

Chakrabarty B, Ito H, Ximenes M, Nishikawa N, Vahabi B, Kanai AJ, Pickering AE, Drake MJ, Fry CH.

Br J Pharmacol. 2019 Jul;176(13):2227-2237. doi: 10.1111/bph.14669. Epub 2019 May 11.

6.

Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study.

Jaggi A, Nazir J, Fatoye F, Siddiqui E, Choudhury N, Argoubi R, Ali M, de Ridder D, Drake MJ.

Neurourol Urodyn. 2019 Jun;38(5):1278-1289. doi: 10.1002/nau.23981. Epub 2019 Mar 28.

7.

Expression and localization of aquaporin water channels in adult pig urinary bladder.

Manso M, Drake MJ, Fry CH, Conway M, Hancock JT, Vahabi B.

J Cell Mol Med. 2019 May;23(5):3772-3775. doi: 10.1111/jcmm.14256. Epub 2019 Mar 25. No abstract available.

8.

Where can urodynamic testing help assess male lower urinary tract symptoms?

Gürbüz C, Drake MJ.

Turk J Urol. 2019 Feb 5;45(3):157-163. doi: 10.5152/tud.2019.82783. Review.

9.

Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis.

Karavitakis M, Kyriazis I, Omar MI, Gravas S, Cornu JN, Drake MJ, Gacci M, Gratzke C, Herrmann TRW, Madersbacher S, Rieken M, Speakman MJ, Tikkinen KAO, Yuan Y, Mamoulakis C.

Eur Urol. 2019 May;75(5):788-798. doi: 10.1016/j.eururo.2019.01.046. Epub 2019 Feb 14.

PMID:
30773327
10.

Modulation of Bladder Wall Micromotions Alters Intravesical Pressure Activity in the Isolated Bladder.

Chakrabarty B, Bijos DA, Vahabi B, Clavica F, Kanai AJ, Pickering AE, Fry CH, Drake MJ.

Front Physiol. 2019 Jan 10;9:1937. doi: 10.3389/fphys.2018.01937. eCollection 2018.

11.

International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function.

Hashim H, Blanker MH, Drake MJ, Djurhuus JC, Meijlink J, Morris V, Petros P, Wen JG, Wein A.

Neurourol Urodyn. 2019 Feb;38(2):499-508. doi: 10.1002/nau.23917. Epub 2019 Jan 15.

PMID:
30644584
12.

Sildenafil, a phosphodiesterase type 5 inhibitor, augments sphincter bursting and bladder afferent activity to enhance storage function and voiding efficiency in mice.

Ito H, Chakrabarty B, Drake MJ, Fry CH, Kanai AJ, Pickering AE.

BJU Int. 2019 Jul;124(1):163-173. doi: 10.1111/bju.14664. Epub 2019 Feb 17.

13.

Fundamentals of terminology in lower urinary tract function.

Drake MJ.

Neurourol Urodyn. 2018 Aug;37(S6):S13-S19. doi: 10.1002/nau.23768. Review.

PMID:
30614063
14.

Neurological lower urinary tract dysfunction essential terminology.

Gajewski JB, Drake MJ.

Neurourol Urodyn. 2018 Aug;37(S6):S25-S31. doi: 10.1002/nau.23758. Review.

PMID:
30614062
15.

The fundamentals of chronic pelvic pain assessment, based on international continence society recommendations.

Rana N, Drake MJ, Rinko R, Dawson M, Whitmore KE.

Neurourol Urodyn. 2018 Aug;37(S6):S32-S38. doi: 10.1002/nau.23776. Review.

PMID:
30614061
17.

The fundamentals of uroflowmetry practice, based on International Continence Society good urodynamic practices recommendations.

Gammie A, Drake MJ.

Neurourol Urodyn. 2018 Aug;37(S6):S44-S49. doi: 10.1002/nau.23777. Review.

PMID:
30614059
18.

Fundamentals of urodynamic practice, based on International Continence Society good urodynamic practices recommendations.

Drake MJ, Doumouchtsis SK, Hashim H, Gammie A.

Neurourol Urodyn. 2018 Aug;37(S6):S50-S60. doi: 10.1002/nau.23773. Review.

PMID:
30614058
19.

How to use the Pelvic Organ Prolapse Quantification (POP-Q) system?

Madhu C, Swift S, Moloney-Geany S, Drake MJ.

Neurourol Urodyn. 2018 Aug;37(S6):S39-S43. doi: 10.1002/nau.23740. Review.

PMID:
30614056
20.

Efficacy and safety of artificial urinary sphincter (AUS): Results of a large multi-institutional cohort of patients with mid-term follow-up.

Tutolo M, Cornu JN, Bauer RM, Ahyai S, Bozzini G, Heesakkers J, Drake MJ, Tikkinen KAO, Launonen E, Larré S, Thiruchelvam N, Lee R, Li P, Favro M, Zaffuto E, Bachmann A, Martinez-Salamanca JI, Pichon T, De Nunzio C, Ammirati E, Haab F, Van Der Aa F.

Neurourol Urodyn. 2019 Feb;38(2):710-718. doi: 10.1002/nau.23901. Epub 2018 Dec 21.

PMID:
30575997
21.

Use of an occlusive penile clamp during filling cystometry in men with symptoms of stress urinary incontinence.

Sharaf A, Fader M, Macaulay M, Drake MJ.

Low Urin Tract Symptoms. 2019 May;11(3):133-138. doi: 10.1111/luts.12249. Epub 2018 Dec 18.

PMID:
30561138
22.

What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT.

Khan R, Uren A, Canham L, Cottrell D, Drake MJ, Cotterill N.

Mult Scler Int. 2018 Oct 18;2018:4721505. doi: 10.1155/2018/4721505. eCollection 2018.

23.

Recommendations for conducting invasive urodynamics for men with lower urinary tract symptoms: Qualitative interview findings from a large randomized controlled trial (UPSTREAM).

Selman LE, Ochieng CA, Lewis AL, Drake MJ, Horwood J.

Neurourol Urodyn. 2019 Jan;38(1):320-329. doi: 10.1002/nau.23855. Epub 2018 Oct 12.

24.

Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB).

Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G, Nitti VW, Oelke M, Smith PP, Yamaguchi O, Wein A, Abrams P.

Neurourol Urodyn. 2018 Nov;37(8):2928-2931. doi: 10.1002/nau.23701. Epub 2018 Sep 11. No abstract available.

PMID:
30203560
25.

What research is needed to validate new urodynamic methods? ICI-RS2017.

Harding C, Rosier PFWM, Drake MJ, Valentini F, Nelson PP, Goping I, Gammie A.

Neurourol Urodyn. 2018 Jun;37(S4):S32-S37. doi: 10.1002/nau.23561.

PMID:
30133795
26.

Fibrosis and the bladder, implications for function ICI-RS 2017.

Fry CH, Kitney DG, Paniker J, Drake MJ, Kanai A, Andersson KE.

Neurourol Urodyn. 2018 Jun;37(S4):S7-S12. doi: 10.1002/nau.23725. Review.

PMID:
30133788
27.

Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).

Drake MJ, Canham L, Cotterill N, Delgado D, Homewood J, Inglis K, Johnson L, Kisanga MC, Owen D, White P, Cottrell D.

BMC Neurol. 2018 Aug 6;18(1):107. doi: 10.1186/s12883-018-1114-4.

28.

Basic concepts in nocturia, based on international continence society standards in nocturnal lower urinary tract function.

Hashim H, Drake MJ.

Neurourol Urodyn. 2018 Aug;37(S6):S20-S24. doi: 10.1002/nau.23781. Epub 2018 Aug 2. Review.

PMID:
30070389
29.

The effect of consultant outcome publication on surgeon behaviour: a systematic review and narrative synthesis.

Williams MP, Modgil V, Drake MJ, Keeley F.

Ann R Coll Surg Engl. 2018 Jul;100(6):428-435. doi: 10.1308/rcsann.2018.0052. Review.

30.

Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in mice.

Ikeda Y, Zabbarova IV, Birder LA, Wipf P, Getchell SE, Tyagi P, Fry CH, Drake MJ, Kanai AJ.

Neurourol Urodyn. 2018 Nov;37(8):2441-2451. doi: 10.1002/nau.23721. Epub 2018 May 28.

31.

Targeting p75 neurotrophin receptors ameliorates spinal cord injury-induced detrusor sphincter dyssynergia in mice.

Zabbarova IV, Ikeda Y, Carder EJ, Wipf P, Wolf-Johnston AS, Birder LA, Yoshimura N, Getchell SE, Almansoori K, Tyagi P, Fry CH, Drake MJ, Kanai AJ.

Neurourol Urodyn. 2018 Nov;37(8):2452-2461. doi: 10.1002/nau.23722. Epub 2018 May 28.

32.

Is Urodynamics Necessary when Assessing a Patient with Male Lower Urinary Tract Symptoms?

Drake MJ.

Eur Urol Focus. 2018 Jan;4(1):54-56. doi: 10.1016/j.euf.2018.04.008. Epub 2018 Apr 26.

PMID:
29705282
33.

The role of urodynamics in the surgical management of benign prostatic obstruction.

Crockett MG, Drake MJ.

Curr Opin Urol. 2018 May;28(3):267-272. doi: 10.1097/MOU.0000000000000496. Review.

PMID:
29528972
34.

Early Surgical Intervention May Be More Likely to Cause Complications in Patients with Male Lower Urinary Tract Symptoms than To Prevent Them.

Drake MJ.

Eur Urol Focus. 2018 Jan;4(1):4-5. doi: 10.1016/j.euf.2018.02.016. Epub 2018 Mar 8.

PMID:
29526701
35.

Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trial.

Constable L, Cotterill N, Cooper D, Glazener C, Drake MJ, Forrest M, Harding C, Kilonzo M, MacLennan G, McCormack K, McDonald A, Mundy A, Norrie J, Pickard R, Ramsay C, Smith R, Wileman S, Abrams P; (Chief Investigator) for the MASTER Study Group.

Trials. 2018 Feb 21;19(1):131. doi: 10.1186/s13063-018-2501-2.

36.

What are the origins and relevance of spontaneous bladder contractions? ICI-RS 2017.

Drake MJ, Fry CH, Hashitani H, Kirschner-Hermanns R, Rahnama'i MS, Speich JE, Tomoe H, Kanai AJ, McCloskey KD.

Neurourol Urodyn. 2018 Jun;37(S4):S13-S19. doi: 10.1002/nau.23485. Epub 2018 Jan 23. Review.

37.

Characterization of mouse neuro-urological dynamics in a novel decerebrate arterially perfused mouse (DAPM) preparation.

Ito H, Drake MJ, Fry CH, Kanai AJ, Pickering AE.

Neurourol Urodyn. 2018 Apr;37(4):1302-1312. doi: 10.1002/nau.23471. Epub 2018 Jan 15.

38.

Definition and symptoms of underactive bladder.

Uren AD, Drake MJ.

Investig Clin Urol. 2017 Dec;58(Suppl 2):S61-S67. doi: 10.4111/icu.2017.58.S2.S61. Epub 2017 Nov 13. Review.

40.

An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD).

Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agrò EF, Dickinson T, Payne CK, Drake MJ, Haylen BT.

Neurourol Urodyn. 2018 Mar;37(3):1152-1161. doi: 10.1002/nau.23397. Epub 2017 Nov 17.

PMID:
29149505
41.

A practical approach to the management of nocturia.

Oelke M, De Wachter S, Drake MJ, Giannantoni A, Kirby M, Orme S, Rees J, van Kerrebroeck P, Everaert K.

Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.13027. Epub 2017 Oct 5. Review.

42.

Statistical analysis plan for the Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM).

Young GJ, Lewis AL, Lane JA, Winton HL, Drake MJ, Blair PS.

Trials. 2017 Oct 3;18(1):455. doi: 10.1186/s13063-017-2206-y.

43.

Treating Overactive Bladder in Older Patients with a Combination of Mirabegron and Solifenacin: A Prespecified Analysis from the BESIDE Study.

Gibson W, MacDiarmid S, Huang M, Siddiqui E, Stölzel M, Choudhury N, Drake MJ.

Eur Urol Focus. 2017 Dec;3(6):629-638. doi: 10.1016/j.euf.2017.08.008. Epub 2017 Sep 12.

PMID:
28916436
44.

The role of stochastic thermal environments in modulating the thermal physiology of an intertidal limpet, Lottia digitalis.

Drake MJ, Miller NA, Todgham AE.

J Exp Biol. 2017 Sep 1;220(Pt 17):3072-3083. doi: 10.1242/jeb.159020.

45.

Long-term adherence to clinical therapy of overactive bladder.

Drake MJ.

Transl Androl Urol. 2017 Jun;6(3):602-603. doi: 10.21037/tau.2017.04.13. No abstract available.

46.

Antioxidants: Is It Simply Too Late Once Lower Urinary Tract Symptoms Are Established? Editorial to [European Urology Focus 2/3 (2016) 310-318].

Drake MJ.

Eur Urol Focus. 2016 Dec 15;2(6):652-653. doi: 10.1016/j.euf.2015.09.009. Epub 2015 Oct 21. No abstract available.

PMID:
28723501
47.

Evaluation and Classification of Stress Urinary Incontinence: Current Concepts and Future Directions.

Osman NI, Li Marzi V, Cornu JN, Drake MJ.

Eur Urol Focus. 2016 Aug;2(3):238-244. doi: 10.1016/j.euf.2016.05.006. Epub 2016 Jun 7. Review.

PMID:
28723369
48.

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.

Drake MJ, Nitti VW, Ginsberg DA, Brucker BM, Hepp Z, McCool R, Glanville JM, Fleetwood K, James D, Chapple CR.

BJU Int. 2017 Nov;120(5):611-622. doi: 10.1111/bju.13945. Epub 2017 Aug 2. Review.

49.

Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms.

Sakalis VI, Karavitakis M, Bedretdinova D, Bach T, Bosch JLHR, Gacci M, Gratzke C, Herrmann TR, Madersbacher S, Mamoulakis C, Tikkinen KAO, Gravas S, Drake MJ.

Eur Urol. 2017 Nov;72(5):757-769. doi: 10.1016/j.eururo.2017.06.010. Epub 2017 Jun 27. Review.

PMID:
28666669
50.

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial.

Herdman M, Nazir J, Hakimi Z, Siddiqui E, Huang M, Pavesi M, MacDiarmid S, Drake MJ, Devlin N.

Patient. 2017 Dec;10(6):677-686. doi: 10.1007/s40271-017-0262-8.

PMID:
28646416

Supplemental Content

Loading ...
Support Center